Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00568
|
|||||
Drug Name |
Minocycline
|
|||||
Synonyms |
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; (4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; 7-Dimethylamino-6-demethyl-6-deoxytetracycline; Borymycin; CL 59806; CRL-1605 & Minocycline; Lactoferrin B & Minocycline; Lactoferrin H & Minocycline; MINO; MIY; Minociclina; Minociclina [INN-Spanish]; Minociclinum; Minocin; Minocin (Hydrochloride); Minocin (TN); Minocline; Minocyclin; Minocycline (USAN/INN); Minocycline Monohydrochloride; Minocycline [USAN:BAN:INN]; Minocyclinum; Minocyclinum [INN-Latin]; Vectrin (Hydrochloride)
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antibiotics
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C23H27N3O7
|
|||||
Canonical SMILES |
CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C
|
|||||
InChI |
InChI=1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1
|
|||||
InChIKey |
FFTVPQUHLQBXQZ-KVUCHLLUSA-N
|
|||||
CAS Number |
CAS 10118-90-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 457.5 | Topological Polar Surface Area | 165 | ||
Heavy Atom Count | 33 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 9 | |||
XLogP |
-0.6
|
|||||
PubChem CID | ||||||
ChEBI ID |
ChEBI:50694
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.